Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. - Test2 - elhamkhani - TriplyDB

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

http://www.wikidata.org/entity/Q34402503

about

Next-generation prognostic assessment for diffuse large B-cell lymphoma Follow-up care for survivors of lymphoma who have received curative-intent treatment Next-generation surveillance strategies for patients with lymphoma Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study Ambulatory Medical Assistance--After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy.Is Radiation Necessary for Treatment of Non-Hodgkin's Lymphoma of Bone? Clinical Results With Contemporary Therapy.Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.Cumulative radiation exposure from imaging procedures and associated lifetime cancer risk for patients with lymphoma.Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful.FDG-PET imaging in hematological malignancies The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials.Rethinking clinical response and outcome assessment in a biologic age.Role and mechanisms of resistance of epidermal growth factor receptor antagonists in the treatment of colorectal cancer.Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.Evolution of lymphoma staging and response evaluation: current limitations and future directions.The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.Imaging of primary pediatric lymphoma of bone.Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.Surveillance Scans in Lymphoma: Friend or Foe?Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.Current imaging follow-up of non-Hodgkin lymphoma exposes patients to significant radiation but does not detect asymptomatic relapses.Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.Minimal residual disease in non-Hodgkin lymphoma - current applications and future directions.Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study.Lack of effectiveness of routine clinic and blood test-based follow-up for diffuse large B cell lymphoma.Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma.Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL).Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma

P2860

Q26796428-F9A96B3B-9536-452F-84E5-C9693576DFA3 Q28077086-E59EEE0B-4571-4EC5-AF47-221169091761 Q28084956-9CFF445A-2DD8-4199-9458-06C45960F5ED Q33851726-E752A5D5-1801-4926-A5EE-89F4D248ACDF Q35198335-51ED143B-5D9A-45E7-9880-445B64C71DF7 Q35700203-B76613EB-ECFF-4421-A63F-A65B96F8337B Q35820192-85167FE7-E6A3-4CDF-8EBF-4AB75263CDA8 Q36558651-FFB473DC-20F9-43EE-8C5D-9A89B967CD66 Q37035820-7003147D-38BD-47DB-9B02-309A413529DD Q37342972-30D99688-29C9-43A5-9641-EF2738874B08 Q37589543-CAE2428D-B27E-44FB-8B65-A36B63E65E5E Q37632114-26914B5F-2766-4201-9A81-192E52EFCD9B Q38268544-D60FCF77-B9F8-4ED7-A7C2-B686A56A40B8 Q38480777-FBF04E6B-2E95-4C79-9DDA-C2BD8BE6BC49 Q38516244-FB656CB6-53C1-4AA1-B92C-879F8EE77486 Q38630219-AB73C7D0-129A-4315-8F1B-C1C7171CD21B Q38642477-7362CF9A-99C6-4BE2-918B-6EAD2F176AA3 Q38671671-86B31384-7B76-4C84-B93F-A60A5EC10748 Q38729502-2D2DF85A-F43E-406D-902A-2B172DA25817 Q38797810-F935152C-9EC7-457C-94FA-E1120668C620 Q38909384-5007FD05-F179-49B5-A734-6C039234977D Q39036785-A45FE165-35E5-422E-ABA1-82E0750A52C4 Q39142301-05664B77-8480-4FDF-9B4E-CDD058C21C50 Q41139081-2AD04D5B-915C-403A-9756-8EB6EA73502C Q41354771-5D301F64-C543-493A-8D5B-A5C9CBC93953 Q47568589-413EFA8C-657C-41E0-AD80-DE94CC088D7E Q47873950-9BD0D17A-2106-4FF7-B04A-82C33AA12F31 Q48105111-7698F2CC-FD9F-4EA8-BE09-89FA7A08D840 Q48171760-2CDF1F77-C1B3-4E13-A13B-96A17802FE28 Q50000153-BAEA0352-A754-40CB-865E-CC21D5DD753B Q50099990-1B5EB5A1-9321-4C3C-B8FE-2F2678DF4BB4 Q52836250-81AB7334-8B9A-4FC4-9FD5-468042D27E38 Q53280595-56A0C35E-3E5F-4305-B885-E3466C8CF3EA Q55024881-1765220F-01E9-4F9C-B78D-CAB9C54B82E0 Q58767936-C2D4A751-4F79-47E7-9218-71756E3E6358

P2860

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

http://www.wikidata.org/entity/Q34402503

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@ast

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@en

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@nl

type

label

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@ast

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@en

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@nl

prefLabel

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@ast

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@en

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

@nl

P1433

Q34402503-3A45F455-564E-4174-8D85-7E286C086906

P1476

Q34402503-A0AA2E5C-F900-4C48-A68F-4D29BCE4FECA

P2093

Q34402503-0A0A0E8D-53FF-46B3-BABB-9D341900A234

Q34402503-0C24D835-24D9-43F4-BF9A-24C387E84CAF

Q34402503-12E20197-330D-4E56-B966-55B2C92486C2

Q34402503-338E2BF9-C1AA-400C-81E5-D35A02D41B82

Q34402503-4022D36F-908D-430B-97EA-D57EF2C1D512

Q34402503-449766C0-172C-456A-8715-F3F1CEA5F377

Q34402503-45D6B56D-7965-4D93-8219-CC6D8B726818

Q34402503-5717AE86-8B0E-4EBC-B734-0456EA4B5017

Q34402503-596CD2E3-10B7-497D-AF51-CF4EFA7A0F35

Q34402503-6A244B4A-4D5F-4437-94BD-B89FF045ABB1

P2860

Q34402503-0B7D5259-2D78-43C8-9E6B-2CBED32A38D0

Q34402503-15D5A838-CB7F-4A8D-AA57-4D2AD49D9045

Q34402503-16E7AB69-574B-4940-BC46-5160305705FB

Q34402503-1B88E769-6AE9-44B5-9F3D-757B1BD632F3

Q34402503-242B9F0B-9DB0-4B4F-AE11-01345E5211AD

Q34402503-3057B569-AC6F-4030-9D4F-8745D0321891

Q34402503-47BED13F-345D-4AD5-9AFE-BF14D93F1DC7

Q34402503-521BF12E-D63E-4CDE-931C-35DD8542325A

Q34402503-550A259B-559D-4E3D-8D46-50F45138141F

Q34402503-5E5E9B3D-B234-4FD0-8E2E-B5CACB74A3C1

P304

Q34402503-21F3D8C5-55F9-4822-B56D-BD68F62BB356

P31

Q34402503-737CB073-8915-4030-907C-2EF82EEDCC4F

P356

Q34402503-495EDB75-1941-4616-9E2E-296BAEE8CD71

P407

Q34402503-8D7B9465-9CD7-4A15-B930-F7F1D13ED880

P433

Q34402503-B9624266-DB12-44D2-89BB-34DFAC3C4EC8

P478

Q34402503-9DC3F7B9-DC49-481E-AA4C-143F37640DBC

P50

Q34402503-27812BC4-570F-405F-8689-7A17B403A6F2

Q34402503-8D13CD6F-4E21-40EC-9435-5A694B5018A2

Q34402503-E8415CF2-15AA-48BF-9F04-2C03D4A5672A

P577

Q34402503-6E27F38F-8928-44ED-B3FD-C20C0304707F

P698

Q34402503-61FA3CE3-1C1F-4571-B22C-4B78130F6A2C

P932

Q34402503-B4B4DBD0-DC7A-414F-A791-AEC6B6514BA7

P356

JCO.2014.55.7561

P1433

Journal of Clinical Oncology

P1476

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma

@en

P2093

Carrie A Thompson

http://www.w3.org/2001/XMLSchema#string

Catherine Chassagne-Clément

http://www.w3.org/2001/XMLSchema#string

Catherine Sebban

http://www.w3.org/2001/XMLSchema#string

David J Inwards

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Nicolas-Virelizier

http://www.w3.org/2001/XMLSchema#string

Grzegorz S Nowakowski

http://www.w3.org/2001/XMLSchema#string

Herve Ghesquieres

http://www.w3.org/2001/XMLSchema#string

Ivana N Micallef

http://www.w3.org/2001/XMLSchema#string

James R Cerhan

http://www.w3.org/2001/XMLSchema#string

Luis F Porrata

http://www.w3.org/2001/XMLSchema#string

P2860

Computed Tomography — An Increasing Source of Radiation Exposure

Cancer statistics, 2013

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits?

The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma.

Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors.

Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas.

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.

P304

3506-3512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2014.55.7561

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

George J Weiner

Matthew J Maurer

P577

2014-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25267745

http://www.w3.org/2001/XMLSchema#string

P932

4209102

http://www.w3.org/2001/XMLSchema#string